Leukemia Specialists

Andrew Zelenetz, MD

Medical Director, Quality Informatics; Attending Physician, Lymphoma Service; Professor of Medicine, Weill Cornell Medicine

Oncology

Daniel Deangelo, M.D.,PH.D.

Chief, Division of Leukemia Institute Physician; Professor of Medicine, Harvard Medical School

Hematology

Stella Davies, M.D.

Director, Division of Bone Marrow Transplantation and Immune Deficiency; Institute Co-Executive Director, Cancer and Blood Diseases Institute; Professor, UC Department of Pediatrics

Pediatrics

Edward Stadtmauer, MD

Director, Hematologic Malignancies Clinical/Translational Research, Division of Hematology/Oncology; Roseman, Tarte, Harrow, and Shaffer Families' President's Distinguished Professor

Hematology

Eric Jacobsen, MD

Associate Professor of Medicine, Harvard Medical School; Clinical Director, Adult Lymphoma Program; Director, Histiocyte Disorders Center

Hematology

Paul Richardson, MD

Director in 2001, and led the study and development of several pivotal novel drugs including thalidomide, lenalidomide, bortezomib, pomalidomide, panobinostat; Professor of Medicine at Harvard Medical School in 2012, and then became Clinical Program Leader and Director of Clinical Research in 2014.

Hematology

James Foran, MD

Hematology

Jaroslaw Maciejewski, MD

Professor of Medicine

Hematology

Sattva Neelapu, M.D.

Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Oncology

Kenneth Anderson, MD

Kraft Family Professor of Medicine, Harvard Medical School; Director, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute

Oncology

Morie Gertz, M.D.

Roland Seidler Jr. Professor of the Art of Medicine; Chair Emeritus, Department of Internal Medicine

Hematology

Thomas Habermann, M.D.

Professor of Medicine, Mayo Clinic

Hematology

Leo Gordon, MD

Professor, Feinberg School of Medicine

Hematology

John Glaspy, MD

Professor of Medicine

Hematology

Stephen Schuster, MD

Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research; Director, Lymphoma Translational Research, Abramson Cancer Center; Associate Professor, Medicine

Hematology

Harry Erba, MD

Professor of Medicine, Duke University School of Medicine; Director, Leukemia Program; Director, Phase I Development in Hematologic Malignancies

Oncology

Jane Winter, MD

Professor, Feinberg School of Medicine, Division of Hematology Oncology

Hematology

Ann Lacasce, M.D.

Associate Professor of Medicine, is a lymphoma specialist and is the Director of the Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology. She serves

Oncology

Nancy Lin, MD

Professor of Medicine at Harvard Medical School, Dr. Lin’s research focuses on developing more effective therapies for patients with metastatic breast ca

Hematology

Vincent Ho, MD

Professor of Medicine, Harvard Medical School; Director of Clinical Operations, Stem Cell Transplantation, Dana-Farber Cancer Institute

Oncology